Grants and Contributions:
Title:
Immunotherapy to preserve beta cell function in Type 1 Diabetes
Agreement Number:
1041103
Agreement Value:
$25,000.00
Agreement Date:
Mar 20, 2026 - Sep 30, 2027
Description:
Advances exploratory research under the New Beginnings Initiative
Organization:
National Research Council Canada
Expected Results:
In the short term, anticipated outcomes will be strengthened collaborations across industry, academia, and government to support research excellence. In the medium term, anticipated outcomes will be the development of new and potentially disruptive technologies with collaborators.
Location:
Montreal, Quebec, CA H1T 2M4
Reference Number:
172-2025-2026-Q4-1041103
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Business Number:
118963214
Recipient Type:
Academia
Recipient's Legal Name:
Centre Intégré Universitaire de Santé et de Services Sociaux de l’Est-de-l’Île-de-Montréal
Federal Riding Name:
Hochelaga--Rosemont-Est
Federal Riding Number:
24026
Program:
Collaborative Science, Technology and Innovation Program – Ideation Fund
Program Purpose:
The Ideation Fund is intended to encourage, test and validate transformative research ideas generated by teams of NRC scientific personnel and external collaborators with complementary capabilities, acting as a demonstration phase for a continually-evolving suite of research and development (R&D) deliverables at the NRC. The fund supports exploratory research through two mechanisms: the New Beginnings Initiative and the Small Teams Initiative.
NAICS Code:
541710 - R&D in the physical, engineering and life sciences